Abstract: A method for producing a high-nickel positive electrode active material, a positive electrode active material produced thereby, and a positive electrode and a lithium secondary battery including the same is provided. The method includes preparing a lithium composite transition metal oxide having a nickel content of 80 atm % or greater among transition metals, washing the lithium composite transition metal oxide, and mixing the washed lithium composite transition metal oxide with an aluminum raw material and heat treating the mixture at a temperature of 650° C. to 690° C. to obtain a positive electrode active material having a surface portion doped with aluminum.

Abstract: A method for manufacturing a semiconductor device and a semiconductor device produced thereby. For example and without limitation, various aspects of this disclosure provide methods for manufacturing a semiconductor device, and semiconductor devices produced thereby, that comprise forming an interposer including a reinforcement layer.

Abstract: The present invention relates to a solution for resource allocation and in particular in relation to resolving a gateway. The solution according to the present invention uses an infix in an access point name, comprising a geographical area, in communicating with a domain name server. The infix is chosen from a list comprising unique combinations of selection criteria.

Abstract: This invention relates to the identification and characterization of specific cellular responses which are associated with tumor necrosis factor receptor 1 (TNFR1) and tumor necrosis factor receptor 1 (TNFR2). Selective modulation of these tumor necrosis factor receptors (TNFRs) Selective modulations of these responses may be useful in the promotion or inhibition of cell growth, for example, in the treatment of disease conditions, including cardiovascular and kidney diseases. Therapeutic methods employed selective TNFR1 and TNFR2 modulators are provided, along with screening methods for the identification of selective TNFR1 and TNFR2 modulators useful in such methods.

Abstract: The present invention relates to a solution for resource allocation and in particular in relation to resolving a gateway. The solution according to the present invention uses an infix in an access point name, comprising a geographical area, in communicating with a domain name server. The infix is chosen from a list comprising unique combinations of selection criteria.

Abstract: The present invention relates to materials and methods for the treatment of arterial diseases having impaired arteriogenesis and angiogenesis. More particularly, the invention provides materials and methods for treating arterial disease using a gene therapy vector expressing Bmx tyrosine kinase.

Abstract: This invention relates to the identification and characterisation of specific cellular responses which are associated with tumour necrosis factor receptor 1 (TNFR1) and tumour necrosis factor receptor 1 (TNFR2). Selective modulation of these tumour necrosis factor receptors (TNFRs) Selective modulations of these responses may be useful in the promotion or inhibition of cell growth, for example, in the treatment of disease conditions, including cardiovascular and kidney diseases. Therapeutic methods employed selective TNFR1 and TNFR2 modulators are provided, along with screening methods for the identification of selective TNFR1 and TNFR2 modulators useful in such methods.

Abstract: The invention relates to an isolated mutant thioredoxin (Trx) molecules and related molecules, including, for example, a thioredoxin mutant resistant to the oxidizing effects of cytokines or reactive oxygen species. The invention further provides various uses, including treatment and diagnostic uses.